What is the share price of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) today?

The share price of AAREYDRUGS as on 16th September 2026 is ₹99.94. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

The past returns of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share are Past 1 week: 1.38%Past 1 month: 15.59%Past 3 months: 27.32%Past 6 months: 59.99%Past 1 year: 41.08%Past 3 years: 108.05%Past 5 years: 166.91%

What are the peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS)?

The peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) include: Aarey Drugs and Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Torrent Pharmaceuticals Ltd Zydus Lifesciences Ltd Cipla Ltd Laurus Labs Ltd

What is the market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹333.34 Cr as of 16th September 2026.

What is the 52 week high and low of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?

The 52-week high of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹101.29 and the 52-week low is ₹50.31.

What is the PE and PB ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) stock?

The P/E (price-to-earnings) ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is 83.75. The P/B (price-to-book) ratio is 2.41.

Which sector does Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belong to?

Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares?

You can directly buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS Share Price

NSE

₹99.941.13% (+1.12)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹329 cr, stock is ranked 2,287

High Risk

Stock is 3.85x as volatile as Nifty

AAREYDRUGS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹329 cr, stock is ranked 2,287

High Risk

Stock is 3.85x as volatile as Nifty

AAREYDRUGS Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
78.85	2.38	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
46.29	5.81	0.49%

AAREYDRUGS Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

AAREYDRUGS Company Profile

Aarey Drugs & Pharmaceuticals is engaged in active pharmaceutical ingredient (API)/Bulk Drugs manufacturing.

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers

AAREYDRUGS Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.35

1Y Return

15.08%

Buy Reco %

93.55

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

85.27

1Y Return

36.60%

Buy Reco %

81.48

Zydus Lifesciences Ltd

ZYDUSLIFE

PE Ratio

21.75

1Y Return

6.59%

Buy Reco %

57.69

Cipla Ltd

CIPLA

PE Ratio

28.13

1Y Return

12.89%

Buy Reco %

62.86

Laurus Labs Ltd

LAURUSLABS

PE Ratio

117.14

1Y Return

112.52%

Buy Reco %

58.33

Compare with Peers

AAREYDRUGS Forecast

AAREYDRUGS Forecasts

AAREYDRUGS

Income

Balance Sheet

Cash Flow

Financial Year		FY 2018		FY 2019		FY 2020		FY 2021		FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	TTM
Total Revenue	352.53	359.08	306.78	355.43	495.43	421.69	402.58	483.75	478.37	420.94
Raw Materials	346.93	347.45	285.93	335.96	461.35	418.98	387.76	472.87	465.10	407.89
Power & Fuel Cost	0.04	0.04	0.01	0.00	0.04	0.03	0.03	0.05
Employee Cost	0.35	0.37	0.29	0.20	0.67	0.63	0.54	0.62
Selling & Administrative Expenses	3.04	3.82	4.94	3.88	6.89	4.52	7.68	6.24
Operating & Other expenses	-8.65	-4.83	5.69	3.73	12.42	-12.93	-4.84	-8.73
EBITDA	10.82	12.23	9.92	11.66	14.06	10.46	11.41	12.70	13.27	13.05
Depreciation/Amortization	0.71	1.01	0.89	0.92	1.99	1.57	1.70	1.94	2.85	3.22
PBIT	10.11	11.22	9.03	10.74	12.07	8.89	9.71	10.76	10.42	9.83
Interest & Other Items	1.92	2.23	1.79	2.44	2.04	2.87	4.38	4.66	5.00	5.63
PBT	8.19	8.99	7.24	8.30	10.03	6.02	5.33	6.10	5.42	4.20
Taxes & Other Items	2.01	2.44	1.45	1.78	3.48	2.24	0.66	2.08	1.44	0.02
Net Income	6.18	6.55	5.79	6.52	6.55	3.78	4.67	4.02	3.98	4.18
EPS	2.98	2.80	2.48	2.79	2.69	1.49	1.75	1.42	1.39	1.47
DPS	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

AAREYDRUGS Income Statement

Quarter		mar 2024		jun 2024		sep 2024		dec 2024		mar 2025	jun 2025	sep 2025	dec 2025	mar 2026	jun 2026
Total Revenue	215.49	128.49	105.16	134.47	115.64	103.76	84.95	100.61	189.04	46.34
Operating & Other expenses	211.79	125.73	101.42	131.59	112.30	100.51	81.52	97.94	185.13	43.30
EBITDA	3.70	2.76	3.74	2.88	3.34	3.25	3.43	2.67	3.91	3.04
Depreciation/Amortization	1.15	0.47	1.51	0.90	0.41	0.49	0.69	0.83	0.85	0.85
PBIT	2.55	2.29	2.23	1.98	2.93	2.76	2.74	1.84	3.06	2.19
Interest & Other Items	0.40	0.96	0.49	0.58	1.30	1.04	1.26	0.92	1.78	1.67
PBT	2.15	1.33	1.74	1.40	1.63	1.72	1.48	0.92	1.28	0.52
Taxes & Other Items	-0.01	0.09	0.15	0.68	1.16	0.36	0.46	0.35	-0.28	-0.51
Net Income	2.16	1.24	1.59	0.72	0.47	1.36	1.02	0.57	1.56	1.03
EPS	0.77	0.44	0.57	0.26	0.17	0.48	0.36	0.20	0.55	0.36

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	5.66	0.62	-20.35	0.69	2.86	5.48	0.50	-1.28	-2.99	10.30
Cash from Investing Activities	-2.58	-4.96	-0.60	-1.23	-0.92	-2.88	-3.21	0.44	-1.70	-5.94
Cash from Financing Activities	-1.63	3.75	23.31	-2.48	-1.80	-2.45	2.25	1.35	5.58	-4.48
Net Change in Cash	+1.45	-0.59	+2.36	-3.02	+0.14	+0.15	-0.46	+0.51	+0.89	-0.12
Changes in Working Capital	+1.48	-12.37	-31.16	-11.54	-7.07	-6.17	-13.51	-11.73	-13.76	-2.41
Capital Expenditures	2.58	4.94	0.62	1.23	0.92	2.88	2.20	1.04	0.72	5.20
Free Cash Flow	3.08	-4.32	-20.97	-0.54	1.94	2.60	-1.70	-2.32	-3.71	5.10

AAREYDRUGS Company Updates

FY 2026FY 2026

Annual report

PDF

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

FY 2023FY 2023

Annual report

PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

AAREYDRUGS Stock Peers

AAREYDRUGS Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Aarey Drugs and Pharmaceuticals Ltd	82.82	2.38	—
Sun Pharmaceutical Industries Ltd	38.35	5.25	0.87%
Torrent Pharmaceuticals Ltd	85.27	10.49	0.70%
Zydus Lifesciences Ltd	21.75	3.71	0.09%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Aarey Drugs and Pharmaceuticals Ltd	Pro
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Aarey Drugs and Pharmaceuticals Ltd	51.86%	80.94	Pro
Sun Pharmaceutical Industries Ltd	20.11%	41.12
Torrent Pharmaceuticals Ltd	22.49%	45.15
Zydus Lifesciences Ltd	23.84%	40.80

AAREYDRUGS Stock Price Comparison

Compare AAREYDRUGS with any stock or ETF

AAREYDRUGS

AAREYDRUGS Holdings

AAREYDRUGS Shareholdings

AAREYDRUGS Promoter Holdings Trend

AAREYDRUGS Institutional Holdings Trend

AAREYDRUGS Shareholding Pattern

AAREYDRUGS Shareholding History

Foreign Institutions

AAREYDRUGS Insider Trades & Bulk Stock Deals

smallcases containing AAREYDRUGS stock

Looks like this stock is not in any smallcase yet.

AAREYDRUGS Events

AAREYDRUGS Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

AAREYDRUGS Dividend Trend

AAREYDRUGS Upcoming Dividends

No upcoming dividends are available

AAREYDRUGS Past Dividends

Cash Dividend

Ex DateEx DateDec 13, 2018

Interim

Interim | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Dec 13, 2018

No upcoming corporate actions are available

Bonus

Ex DateEx DateJun 25, 2012

1:5 Bonus Issue of Equity Shares

1:5 Bonus Issue of Equity Shares | Ratio: 1:5

Ratio

1:5

Ex DateEx Date

Jun 25, 2012

Rights Issue

Ex DateEx DateJan 19, 2012

2:1 Rights Issue of Equity Shares

2:1 Rights Issue of Equity Shares | Ratio: 2:1

Ratio

2:1

Ex DateEx Date

Jan 19, 2012

No upcoming announcements are available

General Updates

Announced OnSep 11, 2026

Aarey Drugs & Pharmaceuticals Limited ha

Aarey Drugs & Pharmaceuticals Limited ha Download

Link

Download

Announced On

Sep 11, 2026

Company Update

Announced OnSep 11, 2026

Aarey Drugs & Pharmaceuticals Ltd - 5244

Aarey Drugs & Pharmaceuticals Ltd - 5244 Download

Link

Download

Announced On

Sep 11, 2026

Copy of Newspaper Publication

Announced OnSep 9, 2026

Aarey Drugs & Pharmaceuticals Limited ha

Aarey Drugs & Pharmaceuticals Limited ha Download

Link

Download

Announced On

Sep 9, 2026

Company Update

Announced OnSep 9, 2026

Aarey Drugs & Pharmaceuticals Ltd - 5244

Aarey Drugs & Pharmaceuticals Ltd - 5244 Download

Link

Download

Announced On

Sep 9, 2026

Shareholders meeting

Announced OnSep 8, 2026

Aarey Drugs & Pharmaceuticals Limited ha

Aarey Drugs & Pharmaceuticals Limited ha Download

Link

Download

Announced On

Sep 8, 2026

AAREYDRUGS Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

AAREYDRUGS Stock News & Opinions

Corporate

AAREY DRUGS to convene board meeting for quarterly results announcement on August 14

AAREY DRUGS & PHARMACEUTICALS LIMITED will hold a board meeting on Friday, August 14, 2026, to approve the unaudited financial results for the quarter ended June 30, 2026, and other matters, according to a filing with the BSE Limited and National Stock Exchange of India Limited. Trading window for the company will be closed from July 1, 2026, and will remain closed until 48 hours after the announcement of the financial results.

1 month agoCapital Market - Live

Earnings

Aarey Drugs & Pharmaceuticals standalone net profit rises 231.91% in the March 2026 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 231.91% to Rs 1.56 crore in the quarter ended March 2026 as against Rs 0.47 crore during the previous quarter ended March 2025. Sales rose 75.27% to Rs 189.47 crore in the quarter ended March 2026 as against Rs 108.10 crore during the previous quarter ended March 2025. For the full year,net profit declined 1.24% to Rs 3.97 crore in the year ended March 2026 as against Rs 4.02 crore during the previous year ended March 2025. Sales declined 0.35% to Rs 472.27 crore in the year ended March 2026 as against Rs 473.94 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales189.47108.10 75 472.27473.94 0 OPM %2.29-3.89 -1.520.61 - PBDT2.132.04 4 8.268.04 3 PBT1.281.63 -21 5.416.10 -11 NP1.560.47 232 3.974.02 -1 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.

3 months agoCapital Market - Live

Earnings

Aarey Drugs & Pharmaceuticals standalone net profit declines 20.83% in the December 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 20.83% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.72 crore during the previous quarter ended December 2024. Sales declined 27.92% to Rs 96.43 crore in the quarter ended December 2025 as against Rs 133.79 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales96.43133.79 -28 OPM %-1.571.64 - PBDT1.752.30 -24 PBT0.921.40 -34 NP0.570.72 -21 Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Aarey Drugs & Pharmaceuticals to discuss results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Aarey Drugs & Pharmaceuticals standalone net profit declines 36.25% in the September 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals declined 36.25% to Rs 1.02 crore in the quarter ended September 2025 as against Rs 1.60 crore during the previous quarter ended September 2024. Sales declined 19.95% to Rs 84.16 crore in the quarter ended September 2025 as against Rs 105.14 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales84.16105.14 -20 OPM %3.143.55 - PBDT2.173.26 -33 PBT1.481.75 -15 NP1.021.60 -36 Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Aarey Drugs & Pharmaceuticals to table results

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Aarey Drugs & Pharmaceuticals to hold AGM

Aarey Drugs & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Earnings

Aarey Drugs & Pharmaceuticals standalone net profit rises 10.48% in the June 2025 quarter

Net profit of Aarey Drugs & Pharmaceuticals rose 10.48% to Rs 1.37 crore in the quarter ended June 2025 as against Rs 1.24 crore during the previous quarter ended June 2024. Sales declined 19.46% to Rs 102.21 crore in the quarter ended June 2025 as against Rs 126.91 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales102.21126.91 -19 OPM %1.670.93 - PBDT2.221.80 23 PBT1.731.33 30 NP1.371.24 10 Powered by Capital Market - Live

1 year agoCapital Market - Live

Corporate

Aarey Drugs & Pharmaceuticals announces board meeting date

Aarey Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 2025.Powered by Capital Market - Live

1 year agoCapital Market - Live

Frequently asked questions

What is the share price of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) today?
The share price of AAREYDRUGS as on 16th September 2026 is ₹99.94. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?
The past returns of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share are
- Past 1 week: 1.38%
- Past 1 month: 15.59%
- Past 3 months: 27.32%
- Past 6 months: 59.99%
- Past 1 year: 41.08%
- Past 3 years: 108.05%
- Past 5 years: 166.91%
What are the peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS)?
The peers or stocks similar to Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) include:
What is the market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹333.34 Cr as of 16th September 2026.
What is the 52 week high and low of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) share?
The 52-week high of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is ₹101.29 and the 52-week low is ₹50.31.
What is the PE and PB ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) stock?
The P/E (price-to-earnings) ratio of Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) is 83.75. The P/B (price-to-book) ratio is 2.41.
Which sector does Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belong to?
Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares?
You can directly buy Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS) shares on Tickertape. Simply sign up, connect your demat account and place your order.